Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salmeterol HandiHaler vs Serevent Diskus in COPD
NCT02238106Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2005
- Primary completion
- Feb 2006
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of salmeterol in chronic obstructive pulmonary disease (COPD) (5 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Change in area under the curve for the time period 0 to 12 hours of the forced expiratory volume in one second. Started Sep 2005; status: completed.
02
Drugs
salmeterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02238106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02238106.